Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

acute coronary syndromealirocumabcerebrovascular diseasedeathmajor adverse cardiac eventsperipheral artery disease